Skip to main content
Quest Diagnostics

Drug Misuse in America 2019

Drug Misuse in America 2019: Physician Perspectives and Diagnostic Insights on the Evolving Drug Crisis, a Quest Diagnostics Health Trends™ report, presents findings from analysis of more than 4.4 million deidentified aggregated clinical drug monitoring tests performed by Quest Diagnostics for patients from all 50 states and District of Columbia from 2011 through 2018.

A collaboration between the Center on Addiction and Quest Diagnostics, this report may be the first of its kind, juxtaposing an analysis of more than 4.4 million deidentified clinical drug monitoring tests by Quest Diagnostics and a survey conducted by The Harris Poll of 500 primary care physicians about their patients’ use of controlled substances.

Click here to learn more and download the report.

Published date: Oct. 18, 2019

2019 Articles

Articles Archive

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.